| abstract |
Formula (I): [wherein R 1 is 2-indanyl, R 2 is 1-methylpropyl, and R 3 is 2,6-dimethyl-3-pyridyl or 4,6-dimethyl-3-pyridyl. R 4 represents methyl, R 5 represents hydrogen or methyl, or R 4 and R 5 together with the nitrogen atoms to which they are bonded represent morpholino] And their pharmaceutically acceptable derivatives, their preparation, pharmaceutical compositions containing the compounds and their use in medicine, in particular as oxytocin antagonists. |